comparison of efficacy of two treatment regimen,cefazolin alone with cefazolin plus metronidazol in the prevention of surgical site infections after hysterectomy

Phase 3

Recruiting

• Conditions: Skin Site Infection after Hysterectomy.; Infection following a procedure; T81.4

• Registration Number: IRCT20200128046289N1
• Lead Sponsor: Babol University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 March 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 400

Inclusion Criteria

All women who are candidates for hysterectomy

Exclusion Criteria

Sensitivities to cefazolin
Sensitivities to metronidazole
sensitivities to penicillins

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Postoperative infection. Timepoint: Twelve months. Method of measurement: Based on ICD-10 Code criteria description.

Secondary Outcome Measures

Name	Time	Method
Prevention of infection after hysterectomy. Timepoint: Thirty days after the hysterectomy. Method of measurement: Clinical signs of wound infection (redness, swelling, warmth, discharge).